Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Amgen (AMGN) Stock Price Prediction and News Highlight
Thu. Apr 3, 2025

Amgen is experiencing significant advancements in drug development, particularly with the recent approval of UPLIZNA as a breakthrough therapy for autoimmune diseases. This progress reflects a robust commitment to innovative therapeutic solutions and expanding the product pipeline, including developments in weight management medications. These advancements are indicative of a dynamic approach to addressing pressing health issues. The focus on innovative product development positions the company well for future growth in a competitive marketplace.

The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2025-04-03. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

AMGN
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-04-030%(0%)    0    0%    0.5          4    -1   
2025-04-020%(0%)    0    0%    0.3          2.6    -1   
2025-04-010%(0%)    0    0%    0.3          2.5    -1   
2025-03-310%(0%)    0    0%    0.2          2.4    -1   
2025-03-280%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-270%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-260%(0%)    0    0%    -0.2          -0.2    -1   
2025-03-250%(0%)    0    0%    -0.2          0    -1   
2025-03-240%(0%)    0    0%    -0          0.9    -1   
2025-03-210%(0%)    0    0%    -0.1          0.3    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-07-18 17:48:24 The approval of UPLIZNA as a breakthrough therapy indicates a strong focus on innovative treatment solutions for serious autoimmune diseases, showcasing continued progress in drug development.
2025-07-18 17:48:24 Reports on Amgen and its stock performance suggest resilience even when broader market conditions are unfavorable, reflecting a potential competitive advantage in the pharmaceutical industry.
2025-07-18 17:48:24 Amid market dips, there is a discussion around potential investment opportunities within the biotech sector, with analysts highlighting specific low-cost Nasdaq stocks poised for recovery.
2025-07-18 17:48:24 Several articles address the substantial decline in the stock market due to tariffs and other economic conditions, indicating growing concerns about market volatility affecting stocks within the pharmaceutical and biotech sectors.
2025-07-18 17:48:24 Recent articles highlight the approval of Amgen's UPLIZNA as both an FDA-approved treatment for IgG4-related disease and its expanded use, showcasing significant advances in regulatory acceptance for new therapies.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA